Incyte Corp (NASDAQ:INCY)

CAPS Rating: 3 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Recs

0
Player Avatar pchop123 (76.49) Submitted: 7/2/2012 11:33:31 AM : Underperform Start Price: $23.86 INCY Score: -8.10

cash burn rate beyond reality making this a marginal play

Featured Broker Partners


Advertisement